| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/02/2003 | EP1191999B1 Method of particle formation |
| 04/02/2003 | EP1165087A4 In vivo stain compounds and methods of use to identify dysplastic tissue |
| 04/02/2003 | EP1153033B1 Method for purifying a red fruit extract containing anthocyanosides |
| 04/02/2003 | EP1143799B1 Multi-purpose acid compositions |
| 04/02/2003 | EP1135126A4 Myt1 kinase inhibitors |
| 04/02/2003 | EP1124841B1 Substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them |
| 04/02/2003 | EP1121108B1 Novel therapeutic use of compounds with beta-3-agonist activity |
| 04/02/2003 | EP1114051B1 INHIBITORS OF p38 |
| 04/02/2003 | EP1096940B1 Biocompatible and biodegradable compositions containing hyaluronic acid and the derivatives thereof for the treatment of ulcers in the digestive apparatus |
| 04/02/2003 | EP1083886B1 Drug delivery system comprising a tightly compacted solid medicament stock |
| 04/02/2003 | EP1071677A4 Production of furanones |
| 04/02/2003 | EP1045863B1 Detoxication of active pharmaceutical substances using cyclodextrine oligomers |
| 04/02/2003 | EP1043993B1 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 04/02/2003 | EP1030842B1 Metalloproteinase inhibitors |
| 04/02/2003 | EP1021456B1 Macrocyclic 13-membered ring derivatives of erythromycins a and b |
| 04/02/2003 | EP1015446B1 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
| 04/02/2003 | EP1000027B1 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
| 04/02/2003 | EP0993304B1 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative |
| 04/02/2003 | EP0991643B1 Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase |
| 04/02/2003 | EP0986570B1 Gemcitabine derivatives |
| 04/02/2003 | EP0986387B1 FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER |
| 04/02/2003 | EP0985671B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT |
| 04/02/2003 | EP0975319B1 Skin care compositions containing an acid and a retinoid |
| 04/02/2003 | EP0966456B1 Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof |
| 04/02/2003 | EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 04/02/2003 | EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
| 04/02/2003 | EP0950409B1 Subepithelial turbidity inhibitor |
| 04/02/2003 | EP0946520B1 Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors |
| 04/02/2003 | EP0946146B1 Use of aqueous medicament preparations for the production of propellent gas-free aerosols |
| 04/02/2003 | EP0934320B1 Naphthyridine derivatives |
| 04/02/2003 | EP0928335B1 METHOD FOR USING OLIGONUCLEOTIDES HAVING MODIFIED CpG DINUCLEOSIDES |
| 04/02/2003 | EP0923592B1 Methods for purifying nucleic acids |
| 04/02/2003 | EP0917458B1 Lyophilized thioxanthenone antimumor agents |
| 04/02/2003 | EP0914460B1 Vehicle for the transport of molecular substances |
| 04/02/2003 | EP0912512B1 Sulphonamide derivatives and their use in the treatment of cns disorders |
| 04/02/2003 | EP0894089B9 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| 04/02/2003 | EP0882029B1 Heterocyclic derivatives as antidiabetic and antiobesity agents |
| 04/02/2003 | EP0880518B1 A process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives |
| 04/02/2003 | EP0880504B1 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 04/02/2003 | EP0874846B1 Purine derivatives and processes for their preparation |
| 04/02/2003 | EP0873295B1 Dimer-selective rxr modulators and methods for their use |
| 04/02/2003 | EP0865445B1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 04/02/2003 | EP0845986B1 Pharmaceutical composition containing 3-(2,2,2-trimethylhydrazinium) propionate and gamma-butyrobetaine for the treatment of cardiovascular diseases |
| 04/02/2003 | EP0828481B1 Oral dosage composition comprising zonula occludens toxin and a biologically active ingredient and use thereof |
| 04/02/2003 | EP0809505B1 Use of pentosan polysulfate for the resolution of scars in chronic progressive vascular diseases |
| 04/02/2003 | EP0804283B1 Aqueous solvent encapsulation method and microcapsules |
| 04/02/2003 | EP0772595B1 Monomeric and dimeric naphthylisoquinoline alkaloids and synthesis methods thereof |
| 04/02/2003 | EP0770081B1 Heterocycle-condensed morphinoid derivatives |
| 04/02/2003 | EP0763049B1 Nucleoside monophosphate derivatives, a process for their production and their use as immunosuppressive drugs |
| 04/02/2003 | EP0724648B1 Methods for screening antiestrogen compounds |
| 04/02/2003 | EP0702518B1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
| 04/02/2003 | EP0681574B1 C7 Taxane derivatives and pharmaceutical compositions containing them |
| 04/02/2003 | EP0675887B1 Antiallergic triazolobenzazepine derivatives |
| 04/02/2003 | EP0621865B1 Rapamycin derivative and its medicinal use |
| 04/02/2003 | EP0610511B1 Composition for dermatologic preparation |
| 04/02/2003 | EP0588912B1 Blended carboxylic acid sanitizer |
| 04/02/2003 | EP0587800B1 Immunomodulatory azaspiranes |
| 04/02/2003 | EP0566732B1 Adeno-associated virus-2 basal vectors |
| 04/02/2003 | CN1407990A C-aryl glucoside sgltz inhibitors |
| 04/02/2003 | CN1407989A Antithrombotic compound |
| 04/02/2003 | CN1407987A Hexahydrofuro'2,3-Blfuran-3-yl-N-´¢ø3'(1,3-benzodioxol-5-ylsulfonyl)(isobutyl) Aminol-1-benzyl-2-hydroxypropyl´¢Øcarbamate as retroviral protease inhibitor |
| 04/02/2003 | CN1407986A Novel imidazotriazinones and the use thereof |
| 04/02/2003 | CN1407985A Heterocyclic dihydropyrimidine as potassium path inhibitor |
| 04/02/2003 | CN1407983A Tert-butyl-(7-methyl-imidazo [1,2-A] pyridine-3-yl)-amine derivatives |
| 04/02/2003 | CN1407982A Serotonergic benzofurans |
| 04/02/2003 | CN1407980A Heterocyclic derivatives |
| 04/02/2003 | CN1407978A Polyhydroxystilbenes and stibene oxides as antisoriatic agents and protein kinase inhibitors |
| 04/02/2003 | CN1407973A Butyne diol derivatives |
| 04/02/2003 | CN1407972A 4-pyrimidine-N-acyl-L-phenylalanines |
| 04/02/2003 | CN1407971A Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/02/2003 | CN1407970A Urea compounds having muscarinic receptor antagonist activity |
| 04/02/2003 | CN1407969A Process for the preparation of oxyiminoalkanoic acid derivatives |
| 04/02/2003 | CN1407968A Adamantane derivatives |
| 04/02/2003 | CN1407903A Concomitant drugs for treating glaucoma |
| 04/02/2003 | CN1407898A Novel topical oestroprogestational compositions with systemic effect |
| 04/02/2003 | CN1407897A DHEA composition and method |
| 04/02/2003 | CN1407896A Exemestane for first-line treatment of breast cancer |
| 04/02/2003 | CN1407895A Pharmaceutical combination of ethinylestradiol and drospirenone for use as contraceptive |
| 04/02/2003 | CN1407894A Pharmaceutical composition |
| 04/02/2003 | CN1407893A Triazinone compounds for treating diseases resulting from infretation with parasitic protozoans |
| 04/02/2003 | CN1407892A Intermittent claudication remedies |
| 04/02/2003 | CN1407891A Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 04/02/2003 | CN1407890A Treatment of psoriasis |
| 04/02/2003 | CN1407889A Flat medicinal preparation for transmucosal administration of oxycodon or comparable active ingredient in oral cavity, for use in pain therapy and in addiction therapy |
| 04/02/2003 | CN1407887A Oral liquid compositions |
| 04/02/2003 | CN1407885A Histamine H2 antagonist effervescent composition |
| 04/02/2003 | CN1407884A Controlled release hydrocodone formulations |
| 04/02/2003 | CN1407857A 低聚糖混合物 Oligosaccharide mixture |
| 04/02/2003 | CN1406950A Human lung cancer antigen and its antibody |
| 04/02/2003 | CN1406948A Peptide as VEGF receptor KDR antagonist |
| 04/02/2003 | CN1406940A Chlorophyll chromium and preparation and use thereof |
| 04/02/2003 | CN1406937A 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it |
| 04/02/2003 | CN1406933A Meso cryptoxanthine preparation |
| 04/02/2003 | CN1406623A Levulose absorption retardant, compound, food and levulose absorption repressor |
| 04/02/2003 | CN1406615A Medicine against for beriberi and sore and boil |
| 04/02/2003 | CN1406603A Weizhen powder for gastrosia |
| 04/02/2003 | CN1406598A Oral cavity ulcer powder and preparation thereof |
| 04/02/2003 | CN1406586A Eye drop containing diuridine phosphoric acid |
| 04/02/2003 | CN1406585A Medicinal composition for viral myocarditis |
| 04/02/2003 | CN1406584A Gel composition for killing parasites |